Meridian Bioscience (VIVO) Reports Q4 EPS of $0.19, Offers FY21 Guidance
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.90 --0%
Financial Fact:
INCOME TAX PROVISION: 3.26M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
INCOME TAX PROVISION: 3.26M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.19, versus $0.14 consensus. Revenue for the quarter came in at $64.2 million, versus $59.6 million consensus.
GUIDANCE:
Meridian Bioscience sees FY2021 EPS of $1.14-$1.28, versus the consensus of $1.02. Meridian Bioscience sees FY2021 revenue of $290-310 million, versus the consensus of $249.15 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Home Depot (HD) Tops Q2 EPS by 19c, reaffirms guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
